Literature DB >> 12414525

Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome.

Kurt H Albertine1, Matthew F Soulier, Zhengming Wang, Akitoshi Ishizaka, Satoru Hashimoto, Guy A Zimmerman, Michael A Matthay, Lorraine B Ware.   

Abstract

Apoptosis mediated by Fas/Fas ligand (FasL) interaction has been implicated in human disease processes, including pulmonary disorders. However, the role of the Fas/FasL system in acute lung injury (ALI) and in the acute respiratory distress syndrome (ARDS) is poorly defined. Accordingly, we investigated both the soluble and cellular expression of the Fas/FasL system in patients with ALI or ARDS. The major findings are summarized as follows. First, the soluble expression of the Fas/FasL system was assessed in undiluted pulmonary edema fluid and simultaneous plasma. Pulmonary edema fluid obtained from patients with ALI or ARDS (n = 51) had significantly higher concentrations of both soluble Fas (27 ng/ml; median; P < 0.05) and soluble FasL (0.125 ng/ml; P < 0.05) compared to control patients with hydrostatic pulmonary edema (n = 40; soluble Fas, 12 ng/ml; soluble FasL, 0.080 ng/ml). In addition, the concentrations of both soluble Fas and soluble FasL were significantly higher in the pulmonary edema fluid of the patients with ALI or ARDS compared to simultaneous plasma samples (soluble Fas, 16 ng/ml; soluble FasL, 0.058 ng/ml; P < 0.05), indicating local release in the lung. Higher soluble Fas concentrations were associated with worse clinical outcomes. Second, cellular expression of the Fas/FasL system was assessed by semiquantitative immunofluorescence microscopy in lung tissue obtained at autopsy from a different set of patients. Both Fas and FasL were immunolocalized to a greater extent in the patients who died with ALI or ARDS (n = 10) than in the patients who died without pulmonary disease (n = 10). Both proteins were co-expressed by epithelial cells that lined the alveolar walls, as well as by inflammatory cells and sloughed epithelial cells that were located in the air spaces. Semiquantitative immunohistochemistry showed that markers of apoptosis (terminal dUTP nick-end labeling, caspase-3, Bax, and p53) were more prevalent in alveolar wall cells from the patients who died with ALI or ARDS compared to the patients who died without pulmonary disease. These findings indicate that alveolar epithelial injury in humans with ALI or ARDS is in part associated with local up-regulation of the Fas/FasL system and activation of the apoptotic cascade in the epithelial cells that line the alveolar air spaces.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414525      PMCID: PMC1850801          DOI: 10.1016/S0002-9440(10)64455-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 2.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

3.  Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome.

Authors:  S Hashimoto; A Kobayashi; K Kooguchi; Y Kitamura; H Onodera; H Nakajima
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

4.  Neural dysfunction during hypoglycaemia.

Authors:  T H Koh; A Aynsley-Green; M Tarbit; J A Eyre
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

5.  Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells.

Authors:  K Nagafuji; T Shibuya; M Harada; S Mizuno; K Takenaka; T Miyamoto; T Okamura; H Gondo; Y Niho
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

6.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

Authors:  J R Le Gall; S Lemeshow; F Saulnier
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

7.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

8.  Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

Authors:  E Rouvier; M F Luciani; P Golstein
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

9.  Fas-mediated cytotoxicity by freshly isolated natural killer cells.

Authors:  H Arase; N Arase; T Saito
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Expression of the functional soluble form of human fas ligand in activated lymphocytes.

Authors:  M Tanaka; T Suda; T Takahashi; S Nagata
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  115 in total

Review 1.  Disorders of lung matrix remodeling.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 2.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

3.  The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.

Authors:  Raquel Herrero; Osamu Kajikawa; Gustavo Matute-Bello; Yi Wang; Naoki Hagimoto; Steve Mongovin; Venus Wong; David R Park; Nathan Brot; Jay W Heinecke; Henry Rosen; Richard B Goodman; Xiaoyun Fu; Thomas R Martin
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

4.  Discovery of the gene signature for acute lung injury in patients with sepsis.

Authors:  Judie A Howrylak; Tamas Dolinay; Lorrie Lucht; Zhaoxi Wang; David C Christiani; Jigme M Sethi; Eric P Xing; Michael P Donahoe; Augustine M K Choi
Journal:  Physiol Genomics       Date:  2009-01-27       Impact factor: 3.107

5.  Relationship of acute lung inflammatory injury to Fas/FasL system.

Authors:  Thomas A Neff; Ren-Feng Guo; Simona B Neff; J Vidya Sarma; Cecilia L Speyer; Hongwei Gao; Kurt D Bernacki; Markus Huber-Lang; Stephanie McGuire; L Marco Hoesel; Niels C Riedemann; Beatrice Beck-Schimmer; Firas S Zetoune; Peter A Ward
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 7.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

8.  IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.

Authors:  Jérémie Roux; Carmel M McNicholas; Michel Carles; Arnaud Goolaerts; Benjamin T Houseman; Dale A Dickinson; Karen E Iles; Lorraine B Ware; Michael A Matthay; Jean-François Pittet
Journal:  FASEB J       Date:  2012-12-06       Impact factor: 5.191

9.  Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice.

Authors:  Reinout A Bem; Job B M van Woensel; Rene Lutter; Joseph B Domachowske; Jan Paul Medema; Helene F Rosenberg; Albert P Bos
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

10.  Mechanical ventilation enhances lung inflammation and caspase activity in a model of mouse pneumovirus infection.

Authors:  Reinout A Bem; Job B M van Woensel; Albert P Bos; Amy Koski; Alex W Farnand; Joseph B Domachowske; Helene F Rosenberg; Thomas R Martin; Gustavo Matute-Bello
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-07       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.